Soligenix, Inc. SEC filings SNGX

Soligenix, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Dec 3, 2008. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 21, 2026 (bylaw or fiscal year change, shareholder vote results, other events). The company's fiscal year ends on December 31.

Soligenix, Inc. SEC filings
Form Description Filed Period
PRER14A Form- prer14a Jul 23, 2026 —
EFFECT Filing Apr 2, 2026 —
EFFECT Filing Apr 2, 2026 —
EFFECT Filing Apr 2, 2026 —
EFFECT Filing Apr 2, 2026 —
EFFECT Filing Sep 25, 2025 —
CORRESP Letter to the SEC Sep 23, 2025 —
CORRESP Letter to the SEC Sep 23, 2025 —
UPLOAD Letter from the SEC Sep 2, 2025 —
DRS Filing Aug 27, 2025 —
EFFECT Filing Mar 26, 2025 —
EFFECT Filing Mar 26, 2025 —
EFFECT Filing Mar 26, 2025 —
EFFECT Filing Aug 2, 2024 —
CORRESP Letter to the SEC Jul 30, 2024 —
UPLOAD Letter from the SEC Jul 29, 2024 —
EFFECT Filing Apr 15, 2024 —
CORRESP Letter to the SEC Apr 15, 2024 —
CORRESP Letter to the SEC Apr 15, 2024 —
CORRESP Letter to the SEC Apr 3, 2024 —
CORRESP Letter to the SEC Apr 2, 2024 —
CORRESP Letter to the SEC Apr 2, 2024 —
UPLOAD Letter from the SEC Jan 19, 2024 —
EFFECT Filing Dec 15, 2023 —
CORRESP Letter to the SEC Dec 14, 2023 —
CORRESP Letter to the SEC Dec 6, 2023 —
CORRESP Letter to the SEC Nov 30, 2023 —
UPLOAD Letter from the SEC Sep 12, 2023 —
NT 10-Q Filing Aug 14, 2023 Jun 30, 2023
EFFECT Filing May 5, 2023 —
CORRESP Letter to the SEC May 4, 2023 —
CORRESP Letter to the SEC Apr 19, 2023 —
UPLOAD Letter from the SEC Apr 7, 2023 —
8-A12G Filing Dec 27, 2022 —
25-NSE Delisting notice Dec 15, 2021 —
NT 10-Q Notification of late filing May 18, 2021 Mar 31, 2021
EFFECT Filing Jan 29, 2021 —
CORRESP Letter to the SEC Jan 27, 2021 —
UPLOAD Letter from the SEC Jan 22, 2021 —
EFFECT Filing Aug 28, 2020 —
CORRESP Letter to the SEC Aug 26, 2020 —
CORRESP Letter to the SEC Jul 31, 2020 —
UPLOAD Letter from the SEC Jul 24, 2020 —
DEFR14A Definitive revised additional materials Aug 17, 2018 —
EFFECT Filing Jun 27, 2018 —
EFFECT Filing Nov 30, 2017 —
UPLOAD Letter from the SEC Nov 28, 2017 —
CORRESP Letter to the SEC Nov 28, 2017 —
D Filing Nov 8, 2017 —
EFFECT Filing Aug 11, 2017 —
CORRESP Letter to the SEC Aug 9, 2017 —
UPLOAD Letter from the SEC May 16, 2017 —
EFFECT Filing May 3, 2017 —
CERTNAS Auto-generated paper document Dec 12, 2016 —
8-A12B For registration of certain classes of securities Dec 12, 2016 —
EFFECT Filing Nov 22, 2016 —
CORRESP Letter to the SEC Nov 22, 2016 —
CORRESP Letter to the SEC Nov 22, 2016 —
CORRESP Letter to the SEC Nov 16, 2016 —
CORRESP Letter to the SEC Nov 15, 2016 —
CORRESP Letter to the SEC Nov 15, 2016 —
UPLOAD Letter from the SEC Oct 17, 2016 —
EFFECT Filing Apr 28, 2016 —
CORRESP Letter to the SEC Apr 26, 2016 —
UPLOAD Letter from the SEC Apr 26, 2016 —
EFFECT Filing Apr 14, 2016 —
EFFECT Filing Apr 14, 2016 —
EFFECT Filing Apr 14, 2016 —
EFFECT Filing Apr 14, 2016 —
CORRESP Letter to the SEC Apr 14, 2016 —
CORRESP Letter to the SEC Apr 13, 2016 —
UPLOAD Letter from the SEC Apr 13, 2016 —
EFFECT Filing Aug 25, 2015 —
CORRESP Letter to the SEC Aug 21, 2015 —
UPLOAD Letter from the SEC Aug 20, 2015 —
EFFECT Filing Apr 6, 2015 —
EFFECT Filing Apr 6, 2015 —
EFFECT Filing Apr 6, 2015 —
EFFECT Filing Dec 30, 2014 —
EFFECT Filing Dec 18, 2014 —
CORRESP Letter to the SEC Dec 17, 2014 —
CORRESP Letter to the SEC Dec 17, 2014 —
CORRESP Letter to the SEC Dec 17, 2014 —
CORRESP Letter to the SEC Nov 17, 2014 —
UPLOAD Letter from the SEC Nov 14, 2014 —
EFFECT Filing Nov 5, 2014 —
CORRESP Letter to the SEC Nov 4, 2014 —
CT ORDER Filing Oct 16, 2014 —
CT ORDER Filing Oct 16, 2014 —
UPLOAD Letter from the SEC Oct 14, 2014 —
EFFECT Filing May 14, 2014 —
EFFECT Filing Apr 21, 2014 —
EFFECT Filing Jan 15, 2014 —
CT ORDER Filing Oct 21, 2013 —
CT ORDER Filing Oct 11, 2013 —
EFFECT Filing Jun 26, 2013 —
EFFECT Filing Jun 20, 2013 —
CORRESP Letter to the SEC Jun 20, 2013 —
CORRESP Letter to the SEC Jun 19, 2013 —
UPLOAD Letter from the SEC Jun 19, 2013 —
CORRESP Letter to the SEC Jun 12, 2013 —
CT ORDER Filing May 29, 2013 —
CT ORDER Filing May 28, 2013 —
D Filing May 3, 2013 —
CORRESP Letter to the SEC Feb 28, 2013 —
CT ORDER Filing Jan 17, 2013 —
UPLOAD Letter from the SEC Nov 20, 2012 —
UPLOAD Letter from the SEC Feb 13, 2012 —
CORRESP Letter to the SEC Feb 7, 2012 —
UPLOAD Letter from the SEC Jan 20, 2012 —
CORRESP Letter to the SEC Dec 23, 2011 —
CORRESP Letter to the SEC Dec 7, 2011 —
UPLOAD Letter from the SEC Dec 5, 2011 —
CT ORDER Filing Sep 1, 2011 —
EFFECT Filing Apr 22, 2011 —
EFFECT Filing Apr 22, 2011 —
EFFECT Filing Apr 22, 2011 —
EFFECT Filing Apr 22, 2011 —
UPLOAD Letter from the SEC Sep 7, 2010 —
CORRESP Letter to the SEC Sep 2, 2010 —
UPLOAD Letter from the SEC Aug 30, 2010 —
CORRESP Letter to the SEC Aug 25, 2010 —
UPLOAD Letter from the SEC Aug 24, 2010 —
EFFECT Filing Jul 13, 2010 —
CORRESP Letter to the SEC Jul 12, 2010 —
CORRESP Letter to the SEC Jul 9, 2010 —
UPLOAD Letter from the SEC Jul 2, 2010 —
D Filing Jul 2, 2010 —
EFFECT Filing May 10, 2010 —
EFFECT Filing Apr 30, 2010 —
EFFECT Filing Apr 30, 2010 —
EFFECT Filing Oct 20, 2009 —
EFFECT Filing May 6, 2009 —
EFFECT Filing Apr 17, 2009 —
DEFR14A Def 14a proxy - revision Apr 17, 2009 —
CORRESP Letter to the SEC Apr 15, 2009 —
CORRESP Letter to the SEC Apr 15, 2009 —
D Filing Mar 24, 2009 —
CT ORDER Filing Mar 4, 2009 —
D Filing Feb 27, 2009 —
UPLOAD Letter from the SEC Feb 25, 2009 —
D Filing Feb 3, 2009 —
D Filing Dec 5, 2008 —

Showing 143 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SNGX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Princeton, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
812796
Former names
SOLIGENIX, INC. (until Nov 2, 2026); DOR BIOPHARMA INC (until Sep 29, 2009); ENDOREX CORP (until Oct 24, 2001); IMMUNOTHERAPEUTICS INC (until Apr 30, 1996)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.